Literature DB >> 24073654

Raised serum levels of interleukins 6 and 8 and antiphospholipid antibodies in an adult patient with Henoch-Schönlein purpura.

S Kimura1, S Takeuchi, Y Soma, T Kawakami.   

Abstract

BACKGROUND: The long-term prognosis of Henoch-Schönlein purpura (HSP) is determined by the severity of renal involvement, known as HSP nephritis, which varies considerably from patient to patient. There is now increasing evidence that dysregulated cytokine production plays a crucial role in human autoimmune and inflammatory processes. AIM: To explore the possible contributions of serum antistreptolysin O, C-reactive protein, IgA, interleukin (IL)-6, IL-8, tumour necrosis factor (TNF)-α, anticardiolipin antibody (aCL) and antiphosphatidylserine-prothrombin complex antibody (anti-PSPT) in the pathogenesis of HSP, and to evaluate correlations between those biological parameters and the clinical features.
METHODS: Records were reviewed of 58 patients with HSP who presented initially with palpable purpura between 2003 and 2009. Serum IL-6 levels were determined by chemiluminescent enzyme immunoassay, IL-8 levels by ELISA and TNF-α levels by quantitative sandwich enzyme immunoassay. Serum aCL and anti-PSPT levels were measured according to our previously published procedures.
RESULTS: There was a significant correlation between the serum IL-6 and IgA anti-PSPT levels, and also between the serum IL-8 and IgA anti-PSPT levels. Serum IL-8 and IgA aCL levels were both significantly higher in patients with renal involvement than in those without. Serum IL-6 and IgM anti-PSPT levels were also significantly higher in patients with gastrointestinal symptoms than in those without.
CONCLUSIONS: We suggest that serum IL-6 and IL-8 associated with antiphospholipid antibodies play a pivotal role in the induction of HSP. Based on our results, IL-8 and IgA aCL levels could be useful as markers to monitor the development of HSP nephritis, and IL-6 and IgM anti-PSPT levels could be used as markers to monitor the development of gastrointestinal involvement.
© 2013 British Association of Dermatologists.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24073654     DOI: 10.1111/ced.12089

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN: 0307-6938            Impact factor:   3.470


  10 in total

Review 1.  [Research advances in immunological pathogenesis of immunoglobulin A vasculitis].

Authors:  Ya-Ting Liu; Si-Guang Lu
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2017-07

2.  Analysis of neutrophil to lymphocyte ratio, platelet to lymphocyte ratio and mean platelet volume to platelet count ratio in children with acute stage of immunoglobulin A vasculitis and assessment of their suitability for predicting the course of the disease.

Authors:  Majka Jaszczura; Anna Góra; Ewa Grzywna-Rozenek; Małgorzata Barć-Czarnecka; Edyta Machura
Journal:  Rheumatol Int       Date:  2019-03-13       Impact factor: 2.631

3.  [Clinical effect and mechanism of hemoperfusion in treatment of children with severe abdominal Henoch-Schönlein purpura].

Authors:  Ying Zhu; Yang Dong; Da-Liang Xu; Jia-Yun Jiang; Lin Wu; Rui-Juan Ke; Shao-Han Fang; Yin Peng
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2018-05

Review 4.  Multicentric Castleman's disease associated with IgA vasculitis (Henoch-Schönlein purpura) responding well to tocilizumab: a case report.

Authors:  Yoichi Oshima; Junichi Hoshino; Tatsuya Suwabe; Noriko Hayami; Masayuki Yamanouchi; Akinari Sekine; Toshiharu Ueno; Hiroki Mizuno; Junko Yabuuchi; Aya Imafuku; Masahiro Kawada; Rikako Hiramatsu; Eiko Hasegawa; Naoki Sawa; Kenmei Takaichi; Nobukazu Hayashi; Takeshi Fujii; Yoshifumi Ubara
Journal:  Clin Rheumatol       Date:  2017-02-06       Impact factor: 3.650

5.  Elevated Serum Interleukin-8 Level as a Preferable Biomarker for Identifying Uncontrolled Asthma and Glucocorticosteroid Responsiveness.

Authors:  Jingxi Zhang; Chong Bai
Journal:  Tanaffos       Date:  2017-06

6.  Changes of inflammatory mediators and oxidative stress indicators in children with Henoch-Schönlein purpura and clinical effects of hemoperfusion in the treatment of severe Henoch-Schönlein purpura with gastrointestinal involvement in children.

Authors:  Ying Zhu; Yang Dong; Lin Wu; Fang Deng
Journal:  BMC Pediatr       Date:  2019-11-04       Impact factor: 2.125

7.  Serum levels of selected cytokines [interleukin (IL)-17A, IL-18, IL-23] and chemokines (RANTES, IP10) in the acute phase of immunoglobulin A vasculitis in children.

Authors:  Majka Jaszczura; Elżbieta Mizgała-Izworska; Elżbieta Świętochowska; Edyta Machura
Journal:  Rheumatol Int       Date:  2019-08-29       Impact factor: 2.631

8.  Association between IL17A and IL17F polymorphisms and risk of Henoch-Schonlein purpura in Chinese children.

Authors:  Hui Xu; Yanxiang Pan; Wei Li; Haidong Fu; Junfeng Zhang; Hongqiang Shen; Xiucui Han
Journal:  Rheumatol Int       Date:  2016-03-28       Impact factor: 3.580

9.  Biomarkers of IgA vasculitis nephritis in children.

Authors:  Evangeline Pillebout; Agnès Jamin; Hamza Ayari; Pierre Housset; Melissa Pierre; Virginia Sauvaget; Denis Viglietti; Georges Deschenes; Renato C Monteiro; Laureline Berthelot
Journal:  PLoS One       Date:  2017-11-30       Impact factor: 3.240

10.  Correlation between serum inflammatory factors TNF-α, IL-8, IL-10 and Henoch-Schonlein purpura with renal function impairment.

Authors:  Liangdong Yuan; Quanyi Wang; Shiqi Zhang; Ling Zhang
Journal:  Exp Ther Med       Date:  2018-02-16       Impact factor: 2.447

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.